Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Accounts Payables (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded Accounts Payables of $3.49 million in Q2 2026, down 51.0% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals reported Accounts Payables of $2.13 million, down 8.3% from FY2024.

  • Across earlier years, Accounts Payables came in at $2.32 million in FY2024.
  • Quarterly Accounts Payables has ranged from $2.13 million in Q4 2025 to $7.12 million in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $7.12 million (Q1 2026), $2.13 million (Q4 2025) and $2.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 9.32 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - 6.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.88 Mn
Jun 30, 2026 3.49 Mn
Mar 31, 2026 7.12 Mn
Dec 31, 2025 2.13 Mn
Sep 30, 2025 2.59 Mn
Dec 31, 2024 2.32 Mn
API Access

Lb Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=LBRX&period=max&api_key=YOUR_API_KEY